OXURION NV (OXUR.BR) Fundamental Analysis & Valuation

EBR:OXUR • BE0974487192

0.006 EUR
+0 (+7.14%)
Last: Mar 6, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership

This OXUR.BR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to OXUR. OXUR was compared to 75 industry peers in the Biotechnology industry. OXUR may be in some trouble as it scores bad on both profitability and health. OXUR has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

3

1. OXUR.BR Profitability Analysis

1.1 Basic Checks

  • In the past year OXUR was profitable.
  • In the past year OXUR has reported a negative cash flow from operations.
  • In the past 5 years OXUR reported 4 times negative net income.
  • In the past 5 years OXUR always reported negative operating cash flow.
OXUR.BR Yearly Net Income VS EBIT VS OCF VS FCFOXUR.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M -40M -60M

1.2 Ratios

  • OXUR has a Return On Assets of 39.34%. This is amongst the best in the industry. OXUR outperforms 97.33% of its industry peers.
Industry RankSector Rank
ROA 39.34%
ROE N/A
ROIC N/A
ROA(3y)-183.9%
ROA(5y)-157.58%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
OXUR.BR Yearly ROA, ROE, ROICOXUR.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K 2K 3K 4K

1.3 Margins

  • With an excellent Profit Margin value of 97950.00%, OXUR belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
  • OXUR has a Operating Margin of 45050.00%. This is amongst the best in the industry. OXUR outperforms 100.00% of its industry peers.
Industry RankSector Rank
OM 45050%
PM (TTM) 97950%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
OXUR.BR Yearly Profit, Operating, Gross MarginsOXUR.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5K -5K 10K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. OXUR.BR Health Analysis

2.1 Basic Checks

  • OXUR does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, OXUR has more shares outstanding
  • OXUR has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for OXUR is higher compared to a year ago.
OXUR.BR Yearly Shares OutstandingOXUR.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
OXUR.BR Yearly Total Debt VS Total AssetsOXUR.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

  • OXUR has an Altman-Z score of -27.36. This is a bad value and indicates that OXUR is not financially healthy and even has some risk of bankruptcy.
  • OXUR has a worse Altman-Z score (-27.36) than 81.33% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -27.36
ROIC/WACCN/A
WACC1.76%
OXUR.BR Yearly LT Debt VS Equity VS FCFOXUR.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

  • A Current Ratio of 0.17 indicates that OXUR may have some problems paying its short term obligations.
  • With a Current ratio value of 0.17, OXUR is not doing good in the industry: 93.33% of the companies in the same industry are doing better.
  • OXUR has a Quick Ratio of 0.17. This is a bad value and indicates that OXUR is not financially healthy enough and could expect problems in meeting its short term obligations.
  • OXUR's Quick ratio of 0.17 is on the low side compared to the rest of the industry. OXUR is outperformed by 93.33% of its industry peers.
Industry RankSector Rank
Current Ratio 0.17
Quick Ratio 0.17
OXUR.BR Yearly Current Assets VS Current LiabilitesOXUR.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. OXUR.BR Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 101.88% over the past year.
  • OXUR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -97.62%.
  • Measured over the past years, OXUR shows a very negative growth in Revenue. The Revenue has been decreasing by -76.22% on average per year.
EPS 1Y (TTM)101.88%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%84.92%
Revenue 1Y (TTM)-97.62%
Revenue growth 3Y-86.15%
Revenue growth 5Y-76.22%
Sales Q2Q%-100%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
OXUR.BR Yearly Revenue VS EstimatesOXUR.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
OXUR.BR Yearly EPS VS EstimatesOXUR.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 -2K -4K -6K -8K -10K

More info and screens

Find the best growth stocksShow best growing peers

3

4. OXUR.BR Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 0.01, which indicates a rather cheap valuation of OXUR.
  • Based on the Price/Earnings ratio, OXUR is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
  • When comparing the Price/Earnings ratio of OXUR to the average of the S&P500 Index (26.29), we can say OXUR is valued rather cheaply.
Industry RankSector Rank
PE 0.01
Fwd PE N/A
OXUR.BR Price Earnings VS Forward Price EarningsOXUR.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, OXUR is valued cheaper than 86.67% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 11.58
OXUR.BR Per share dataOXUR.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. OXUR.BR Dividend Analysis

5.1 Amount

  • No dividends for OXUR!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

OXUR.BR Fundamentals: All Metrics, Ratios and Statistics

OXURION NV

EBR:OXUR (3/6/2026, 7:00:00 PM)

0.006

+0 (+7.14%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)09-30
Earnings (Next)04-03
Inst Owners0.22%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap420.60K
Revenue(TTM)2.00K
Net Income(TTM)1.96M
Analysts42.22
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 0.01
Fwd PE N/A
P/S 210.3
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 11.58
EPS(TTM)0.61
EY10166.67%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0
BVpS-0.17
TBVpS-0.17
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 39.34%
ROE N/A
ROCE -7.59%
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 45050%
PM (TTM) 97950%
GM N/A
FCFM N/A
ROA(3y)-183.9%
ROA(5y)-157.58%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 4.92
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.17
Quick Ratio 0.17
Altman-Z -27.36
F-Score4
WACC1.76%
ROIC/WACCN/A
Cap/Depr(3y)1.58%
Cap/Depr(5y)3.23%
Cap/Sales(3y)3.43%
Cap/Sales(5y)3.77%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)101.88%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%84.92%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-97.62%
Revenue growth 3Y-86.15%
Revenue growth 5Y-76.22%
Sales Q2Q%-100%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y112.45%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y87.88%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y87.87%
OCF growth 3YN/A
OCF growth 5YN/A

OXURION NV / OXUR.BR FAQ

What is the ChartMill fundamental rating of OXURION NV (OXUR.BR) stock?

ChartMill assigns a fundamental rating of 2 / 10 to OXUR.BR.


What is the valuation status for OXUR stock?

ChartMill assigns a valuation rating of 3 / 10 to OXURION NV (OXUR.BR). This can be considered as Overvalued.


Can you provide the profitability details for OXURION NV?

OXURION NV (OXUR.BR) has a profitability rating of 3 / 10.


Can you provide the financial health for OXUR stock?

The financial health rating of OXURION NV (OXUR.BR) is 0 / 10.